Physician
Vivid Pathology PA
Vivid Pathology PA was paid $1.75M by Medicaid between Jan 2019 and Dec 2024, across 158 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 21% of everything it billed.
33Billing provider infoVIVID PATHOLOGY PA
PENSACOLA, FL 32504
PENSACOLA, FL 32504
33aNPI1760738611assigned 07/30/2012
33bProvider typeHematology (Pathology) Physician
28Total paid$1.75M
24GClaims652,448
24DCodes billed158
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other Hematology (Pathology) Physician providers in Florida
Rank by total paid#1 of 8
Median peer was paid$4K
This provider vs. median408×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 96,070 | $315K | |
| 2020 | 75,121 | $344K | |
| 2021 | 97,783 | $305K | |
| 2022 | 90,998 | $269K | |
| 2023 | 239,707 | $387K | |
| 2024incomplete | 52,769 | $134K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 21% | 10,696 | 9,132 | $365K |
| 88307 | 17% | 6,212 | 5,639 | $301K | |
| 80053 | Comprehensive metabolic panel | 13% | 71,813 | 44,614 | $229K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.2% | 1,653 | 1,570 | $91K |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.0% | 31,465 | 15,657 | $70K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.8% | 97,346 | 57,638 | $66K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.0% | 3,516 | 2,922 | $36K |
| 82805 | 2.0% | 5,799 | 3,407 | $35K | |
| 85060 | 1.5% | 1,672 | 1,465 | $27K | |
| 81001 | 1.4% | 38,154 | 29,722 | $24K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1.3% | 3,285 | 2,150 | $22K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.2% | 4,282 | 2,899 | $20K |
146 more codes
| 87486 | 1.1% | 4,249 | $19K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 10,413 | $17K |
| 83735 | <1% | 25,813 | $16K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 490 | $15K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,214 | $15K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,170 | $14K |
| 84484 | <1% | 12,445 | $14K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 3,783 | $13K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,153 | $13K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,361 | $13K |
| 88304 | <1% | 764 | $13K | |
| 87040 | <1% | 7,885 | $12K | |
| 82962 | <1% | 21,601 | $12K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 4,414 | $11K |
| 87581 | <1% | 4,349 | $11K | |
| 81513 | <1% | 530 | $11K | |
| 86900 | <1% | 16,526 | $11K | |
| 85027 | <1% | 14,976 | $9K | |
| 88342 | <1% | 1,063 | $9K | |
| 83605 | <1% | 7,819 | $9K | |
| 84703 | <1% | 14,856 | $8K | |
| 86850 | <1% | 11,171 | $8K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 535 | $8K |
| 83020 | <1% | 1,537 | $7K | |
| 80061 | Lipid panel | <1% | 7,089 | $7K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 10,486 | $7K |
| 83690 | <1% | 15,512 | $7K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,141 | $7K |
| 87077 | <1% | 5,932 | $6K | |
| 88141 | <1% | 939 | $6K | |
| 86803 | <1% | 3,008 | $6K | |
| 82375 | <1% | 4,095 | $6K | |
| 87070 | <1% | 2,016 | $6K | |
| 86920 | <1% | 967 | $6K | |
| 82553 | <1% | 2,732 | $5K | |
| 84702 | <1% | 3,783 | $5K | |
| 88108 | <1% | 449 | $5K | |
| 82330 | <1% | 2,986 | $5K | |
| 82728 | <1% | 3,199 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,443 | $4K |
| 85610 | <1% | 10,448 | $4K | |
| 86140 | <1% | 7,987 | $4K | |
| 86901 | <1% | 16,617 | $4K | |
| 87186 | <1% | 3,832 | $4K | |
| 80074 | <1% | 627 | $3K | |
| 80076 | <1% | 4,637 | $3K | |
| 82607 | <1% | 2,465 | $3K | |
| 87205 | <1% | 2,844 | $3K | |
| 85730 | <1% | 5,552 | $3K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 916 | $3K |
| 81003 | <1% | 4,079 | $3K | |
| 84439 | <1% | 3,623 | $3K | |
| 87340 | <1% | 3,348 | $2K | |
| 82950 | <1% | 2,154 | $2K | |
| 83050 | <1% | 4,114 | $2K | |
| 87481 | <1% | 336 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 371 | $2K |
| 84466 | <1% | 1,545 | $2K | |
| 83615 | <1% | 3,878 | $2K | |
| 82565 | <1% | 963 | $2K | |
| 82746 | <1% | 1,514 | $2K | |
| 86762 | <1% | 1,980 | $2K | |
| 82140 | <1% | 749 | $1K | |
| 82247 | <1% | 3,411 | $1K | |
| 82570 | <1% | 2,907 | $1K | |
| 87081 | <1% | 1,391 | $1K | |
| 87653 | <1% | 489 | $1K | |
| 86592 | <1% | 4,215 | $1K | |
| 83540 | <1% | 2,325 | $1K | |
| 80202 | <1% | 557 | $1K | |
| 85045 | <1% | 2,873 | $942.74 | |
| 82947 | <1% | 822 | $939.13 | |
| 84165 | <1% | 1,070 | $869.20 | |
| 84156 | <1% | 2,368 | $841.25 | |
| 87210 | <1% | 2,263 | $787.45 | |
| 85379 | <1% | 1,252 | $741.70 | |
| 87428 | <1% | 33 | $724.98 | |
| 85652 | <1% | 2,634 | $634.29 | |
| 83525 | <1% | 527 | $603.67 | |
| 85018 | <1% | 982 | $580.73 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 786 | $532.55 |
| 83970 | <1% | 126 | $497.30 | |
| 80320 | <1% | 319 | $416.80 | |
| 82248 | <1% | 1,557 | $407.82 | |
| 86880 | <1% | 1,098 | $356.84 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 109 | $315.36 |
| 83550 | <1% | 487 | $300.39 | |
| 82378 | <1% | 189 | $294.05 | |
| 82784 | <1% | 296 | $283.56 | |
| 87075 | <1% | 342 | $259.08 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,055 | $256.53 |
| 86703 | <1% | 172 | $217.99 | |
| 85384 | <1% | 238 | $193.69 | |
| 84132 | <1% | 196 | $185.26 | |
| 82150 | <1% | 473 | $178.32 | |
| 87015 | <1% | 219 | $175.78 | |
| 86922 | <1% | 46 | $160.00 | |
| 80055 | <1% | 51 | $155.73 | |
| 86320 | <1% | 113 | $149.03 | |
| 86706 | <1% | 223 | $146.05 | |
| 83880 | <1% | 440 | $144.04 | |
| 82040 | <1% | 536 | $110.33 | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 75 | $110.00 |
| 86696 | <1% | 86 | $102.07 | |
| 84480 | <1% | 70 | $92.14 | |
| 86431 | <1% | 13 | $90.90 | |
| 88311 | <1% | 71 | $90.26 | |
| 84295 | <1% | 154 | $84.15 | |
| 87641 | <1% | 16 | $71.10 | |
| 84550 | <1% | 298 | $70.50 | |
| 86695 | <1% | 89 | $68.75 | |
| 86923 | <1% | 628 | $65.84 | |
| 82009 | <1% | 240 | $63.60 | |
| 84450 | <1% | 178 | $62.09 | |
| 80069 | <1% | 113 | $58.57 | |
| 82435 | <1% | 115 | $56.72 | |
| 84145 | <1% | 462 | $55.12 | |
| 82951 | <1% | 37 | $52.82 | |
| 86787 | <1% | 92 | $51.13 | |
| 84481 | <1% | 52 | $49.86 | |
| 80050 | General health panel | <1% | 133 | $39.67 |
| 87102 | <1% | 14 | $37.05 | |
| 84460 | <1% | 197 | $35.64 | |
| 87045 | <1% | 28 | $35.00 | |
| 86304 | <1% | 33 | $34.83 | |
| 87807 | <1% | 13 | $24.70 | |
| 86038 | <1% | 29 | $24.30 | |
| 84520 | <1% | 147 | $20.64 | |
| 85651 | <1% | 74 | $20.49 | |
| 86704 | <1% | 27 | $20.46 | |
| 87449 | <1% | 20 | $14.92 | |
| 87324 | <1% | 20 | $14.92 | |
| 82977 | <1% | 54 | $13.43 | |
| 84112 | <1% | 28 | $12.88 | |
| 86141 | <1% | 18 | $11.51 | |
| 82043 | <1% | 53 | $8.64 | |
| 87220 | <1% | 29 | $7.20 | |
| 86709 | <1% | 12 | $6.80 | |
| 89051 | <1% | 16 | $6.23 | |
| 85046 | <1% | 18 | $5.67 | |
| 84436 | <1% | 27 | $3.72 | |
| 87046 | <1% | 29 | $3.08 | |
| 86780 | <1% | 33 | $2.15 | |
| 84155 | <1% | 14 | $1.30 | |
| 87147 | <1% | 25 | $0.80 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDADIMAN, CHRISTOPHER (PRESIDENT)